Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
06/2010
06/23/2010CN101748099A Noble cell of human embryonic stem cell for stably expressing HLA-G molecules
06/23/2010CN101748046A Full temperature micro volume blending incubation and hybridization instrument
06/23/2010CN101747436A Specific antibody against pesticide phosmet
06/23/2010CN101747433A Dracorhodin enzyme linked immunization detection method and application
06/23/2010CN101747422A Schistosoma japonica fatty acid-binding protein and coding gene and application thereof
06/23/2010CN101745495A Method for inhibiting non-specific adsorption of solid material surface
06/23/2010CN101745286A Discharge gas treatment apparatus and its treatment method
06/23/2010CN101745035A Quality control method of capsule preparation for treating apoplexy
06/23/2010CN101744880A Quality control method for total salvianolic acid injection
06/23/2010CN101354354B Color development liquid for peroxidase mensuration and preparation method thereof
06/23/2010CN101329279B Method for rapidly testing cysteine in water solution
06/23/2010CN101323881B Chromosome localization method of scallop (Chlamys farreri)
06/23/2010CA2653163A1 Methods for the treatment of acute myeloid leukemia
06/22/2010US7742878 Bio-expression system and the method of the same
06/22/2010US7742877 Methods, apparatus and computer program products for formulating culture media
06/22/2010US7742800 Methods and systems for detection and monitoring of neurodegenerative diseases using magnetic resonance spectroscopy
06/22/2010US7741529 mice which comprise a mutation in the gene encoding for the cardiac ryanodine receptor (RyR2); used in drug screening and for understanding the molecular basis of RyR2 dependent arrhythmias
06/22/2010US7741463 Used in solid-phase nucleic acid amplification; producing template polynucleotides that have common sequences at their 5' ends and at their 3' ends
06/22/2010US7741458 Spinocerebellar ataxia type 8 and methods of detection
06/22/2010US7741451 Antibodies that specifically bind hedgehog-derived polypeptides
06/22/2010US7741447 Antibody against tumor specific antigen as target
06/22/2010US7741445 Multidrug resistance proteins; xenobiotic transporters; counteracting the mechanism of drug resistance so to provide a longer and more effective course of chemotherapeutic drug treatment for cancer patients
06/22/2010US7741443 human C-type lectin; diagnosis, prevention and/or treatment of neoplastic disorders and diseases
06/22/2010US7741439 Isolated stra6 polypeptides
06/22/2010US7741335 administering nontoxic, preferential and potent c-kit ligand inhibitors such as imatinib, to humans for treatment of inflammatory diseases such as rheumatoid arthritis
06/22/2010US7741310 A polynucleotide encodes an arginase, a nerve growth factors for treating nervous system disorders, neurodegenerative diseases
06/22/2010US7741298 Using interfering Rna; blocking antibodies
06/22/2010US7741288 serine/threonine phosphatases (PP1); immobilization, screening
06/22/2010US7741278 Modified proteins, designer toxins, and methods of making thereof
06/22/2010US7741272 Inhibiting angiogenesis in a mammal by administering Eph receptor antagonist ; cardiovascular disorders
06/22/2010US7741271 atopic diseases such as allergies, asthma, eosinophilia, glomerulonephritis; hyperplastic conditions such as cancer; T cell immunologobulin and mucin domain (TIM)
06/22/2010US7741270 Luminescent markers
06/22/2010US7741130 Microfluidic system comprising a first fluid path, and a second fluid path separated by a controller, path has a cross-sectional dimension of less than about 1 mm; promoting interaction, immobilizing a material; biological analyzer; multitask genomic analysis
06/22/2010US7741129 Subjecting magnetic particles to a constant magnetic field; orienting the particles in filaments along the north-south axis of the magnetisation source, moving the magnetisation source and/or the vessel, while maintaining magnetisation on the magnetic particles; antibodies, antigens, nucleic acids
06/22/2010US7741128 Using nanoscale, self-signaling, antibody biosensors for use in single-step detection of preferential particle in solution
06/22/2010US7741126 Computers for assigning glycans to mass peaks; constructing monosaccharide set table, applying rules based on experimental or biosynthetic conditions
06/22/2010US7741125 Biosensor, biosensor measuring apparatus and measurement method
06/22/2010US7741124 Using matrix independent turbidimetry to determine fibrinogen concentration and diagnose/prognose atherothrombotic diseases; based on a measurement of turbidity
06/22/2010US7741122 determining the total base number (TBN) of a used lubricating oil by measuring with a spectroscopic device at least one element, such as sulfur, and correlating the measured amount to the oil's TBN
06/22/2010US7741120 improved detection/characterization of biomolecules by taking advantage of multifunctional properties of the composite nanocrystal, e.g., an optical reporter function for detection coupled with a magnetic label for collection
06/22/2010US7741106 Sensors for biomolecular detection and cell classification
06/22/2010US7741104 includes a substrate with a channel formed in its surface, a cover element that overlies and seals the channel; for detecting the presence of one or more target analytes in a sample employing a channel having affixed therein one or more binding partners for each target analyte
06/22/2010US7741103 Integrated screening and confirmation device
06/22/2010US7741102 Surface enhanced (resonance) Raman scattering with 2,4,6-trinitrostyryl-1H-benzotriazole; for detection of explosives and drugs; drug screening
06/22/2010US7741080 elucidate the functional mechanism of adipocyte hypertrophy-dependent suppression of adiponectin production; identifies factors that can increase the expression of adiponectin gene; provides adiponectin expression-inducing agents; metabolic or heart diseases
06/22/2010US7741066 Phosphorylated p68 RNA helicase as a marker for cancer and cancer metastasis
06/22/2010US7741065 liver disease or condition, detecting liver function and assessing the efficacy of therapy to a liver disease; detecting a level of sH2a in
06/22/2010US7741064 biological reagents comprising the GPCR oligomers, methods of producing said biological reagents and assays for determining their function; determining compounds that have the ability to modulate the function of GPCR oligomers
06/22/2010US7741063 fusion protein that is antigenic and effective to elicit an immune response against Toxoplasma gondii oocysts
06/22/2010US7741062 Epitope-captured antibody display
06/22/2010US7741061 Polysaccharide structure and sequence determination
06/22/2010US7741060 Parathyroid hormone component comprising matrix protein for use as diagnostic control in monitoring hormone levels; bioassay
06/22/2010US7741059 Methods and compositions for detection of Ehrlichia chaffeensis (p120)
06/22/2010US7741058 Methods and compositions for detecting spermatozoa or semen in a sample
06/22/2010US7741057 Method for screening for compounds using MHC class II invariant chain polypeptide and macrophage migration inhibitory factor
06/22/2010US7741056 Junctional Adhesion Molecule (JAM); treating and diagnosing disorders characterized the by the presence of antigens associated with inflammatory diseases and/or cancer; antagonist of a native sequence STIgMA polypeptide
06/22/2010US7741055 prostate cancer and benign prostatic hyperplasia; promote tissue regeneration and to facilitate wound healing
06/22/2010US7741054 High throughput prion assays
06/22/2010US7741053 antibody that binds to a metal ion-affinity peptide having a high affinity for coordinated metals and also being highly antigenic
06/22/2010US7741052 Method of assessing the risk of atherosclerosis
06/22/2010US7741051 a fragment derived from the MET ectodomain in monomer form binds to hepatocyte growth factor/scatter factor (HGF/SF) either in the presence or absence of heparin; method for determining whether an agent binds to a MET ectodomain fragment in monomeric form
06/22/2010US7741050 autoantibodies which recognize extracellular structures of G protein-coupled receptors; autoimmune diseases; Raynaud's syndrome, cardiomyopathy, myocarditis, hypertension
06/22/2010US7741049 Detection of receptor agonist; obtain sample containing receptor, incubate with modulator, monitor signal from receptor
06/22/2010US7741048 quantitating levels of MN/CA9 gene expression products in patients afflicted with preneoplastic/neoplastic diseases of tissues, wherein the normal tissue associated with such a preneoplastic/neoplastic disease expresses CA IX, but loses CA IX expression upon carcinogenesis
06/22/2010US7741047 Using histone binding protein (RBAp48) as evaluative tool in identifying modulators for treatment of sjogren's syndrome
06/22/2010US7741046 Sequential analysis of biological samples
06/22/2010US7741045 Sequential analysis of biological samples
06/22/2010US7741044 dividing the support into lots, performing a different chemical reaction on each lot of the support, tagging a fraction of each lot of the support with a different label, and combining the said lots of the support; used in assays and nucleic acid analysis
06/22/2010US7741041 A IJ-system reagent inspection device 3 that instructs an ejection device to eject a reagent and reads an inspection result from a detachable DNA chip module 2; Ejecting a liquid reagent onto DNA chip module; communicating means for transmitting and receiving data
06/22/2010US7741039 Postweaning multisystemic wasting syndrome virus from pigs
06/22/2010US7741038 Methods and compositions for evaluating graft survival in a solid organ transplant recipient
06/22/2010US7741037 Method for pheromone discovery in insects
06/22/2010US7741035 profiling in multiple myeloma patients identifies genes that distinguish between patients with subsequent early death or long survival after treatment; using ASPM, OPN3 and CKS1B genes as biomarkers
06/22/2010US7741030 detecting whether CpG sequences in a region from base 374 to base 592 in a DR3 gene promoter region obtained from synovial cells or synovial infiltrating lymphocytes of the human subject are methylated or not
06/22/2010US7741024 used as immunogens to elicit immune reaction, screening assays, including as antigens to screen antibody libraries, as well as for drug screening and the identification of ligands
06/22/2010US7741023 Method for predicting immune response to neoplastic disease based on mRNA expression profile in neoplastic cells and stimulated leukocytes
06/22/2010US7741021 Detecting and modulating post-translational O-sulfonation of serine and threonine residues on polypeptides
06/22/2010US7741019 Prognosing and monitoring urogenital cell proliferative disorders; tumor imaging and analysis
06/22/2010US7740870 Group B Streptococcus antigens and corresponding DNA fragments
06/22/2010US7740859 detection of anti-leishmanial antibodies in individuals suspected of infection with the protozoan parasite of the genus Leishmania especially Indian Leishmania strains; kits; vaccine and therapeutic agent to prevent and treat leishmaniasis
06/22/2010US7740852 Binding molecules capable of neutralizing rabies virus and uses thereof
06/22/2010US7740841 Therapeutic method for reducing angiogenesis
06/22/2010US7740834 Murine zcytor17 ligand polypeptides
06/22/2010US7740833 Therapeutic uses of chemokine variants
06/22/2010US7740830 Imaging, diagnosis and treatment of disease
06/22/2010US7740803 Biochemical sensor with thermoelastic probes
06/22/2010US7740424 Article separation apparatus and method for unit operations
06/22/2010CA2497883C Method for distinguishing ulcerative colitis from crohn's disease by detecting the presence of fecal anti-neutrophil cytoplasmic antibodies (anca)
06/22/2010CA2486161C Wireless environmental sensor
06/22/2010CA2483757C On-board control for analytical elements
06/22/2010CA2466362C Improved rhodium electrocatalyst and method of preparation
06/22/2010CA2445881C Reagents and methods for automated hybridization
06/22/2010CA2441071C Tsg101-gag interaction and use thereof
06/22/2010CA2434067C Materials and methods relating to protein aggregation in neurodegenerative disease
06/22/2010CA2433431C Method of mass spectrometry and a mass spectrometer
06/22/2010CA2389741C Assay device and use thereof
06/22/2010CA2369672C Transgenic animals expressing salivary proteins
06/22/2010CA2367688C Biological indicators for validating a prion sterilization-process
06/22/2010CA2356697C Accelerating identification of single nucleotide polymorphisms and alignment of clones in genomic sequencing
06/22/2010CA2337491C Human mink gene mutations associated with arrhythmia